[Trial treatment of chronic myeloid leukemia with 3 new chemotherapeutic agents: dibromomannitol, hydroxyurea and desacetamidocolchicine].
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003078:Colchicine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008297:Male; D008353:Mannitol / Q000627:therapeutic use*; D014508:Urea / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D008353:Mannitol; D014508:Urea; D003078:Colchicine; D006918:Hydroxyurea
Essai de traitement de la leucémie myéloïde chronique par 3 nouveaux composés chimiothérapiques: le dibromomannitol, l'hydroxyurée et la désacétamidocolchicine.